RxDoctor Payments DataLook up a doctor →

Mitchell Bernsen, MD

Gastroenterology · Arlington Heights, ILNPI 1275523631

Payments from drug & device makers

$220,104in general payments, 2019–2025

Across 708 payments — averaging $310.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$74K
  • AbbVie$50K
  • E.r. Squibb & Sons, L.L.C.$42K
  • Gilead$27K
  • UCB Biosciences Inc.$10K
  • Pfizer$9K
  • plus $9K from 33 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Takeda Pharmaceuticals U.S.A., Inc.151$74,377
AbbVie(2 entities)148$49,849
E.r. Squibb & Sons, L.L.C.4$41,608
Gilead27$27,006
UCB Biosciences Inc.4$10,000
Pfizer(2 entities)47$8,518
Johnson & Johnson(2 entities)118$2,958
Gastrogpo, LLC6$1,746
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC23$466
Sanofi11$346
Regeneron Healthcare Solutions, Inc.10$288
Bristol Myers Squibb24$258
Madrigal Pharmaceuticals7$242
Ardelyx, Inc.10$216
QOL Medical, LLC9$204
Celltrion USA Inc.10$199
Intercept Pharmaceuticals, Inc.9$191
Ferring Pharmaceuticals Inc.9$181
Lilly USA, LLC7$165
Ironwood Pharmaceuticals, Inc10$165
UCB, Inc.13$149
Ipsen Biopharmaceuticals, Inc5$144
Merck8$141
Phathom Pharmaceuticals, Inc.8$138
Braintree Laboratories, Inc.6$87
Amgen4$86
Organon4$79
Boehringer Ingelheim2$53
Concordia Pharmaceuticals Inc.2$36
Evoke Pharma, Inc.2$31
Biocon Biologics Inc1$28
Daiichi Sankyo Inc.1$25
Sandoz1$24
Endo Pharmaceuticals Inc.1$24
Medtronic1$17
Nestle Healthcare Nutrition Inc.1$16
Echosens North America, Inc.1$16
Dova Pharmaceuticals1$14
Romark Laboratories, LC2$13

How this compares

$220,104 in reported general payments places this provider in the 90th percentile of 787 gastroenterology providers in Illinois.

See all gastroenterology providers in Illinois →

Medicare billing

Part B allowed, 2024
$459,615
Medicare patients
582
Services billed
15,315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Arlington Heights

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →